Analysis of Gout Remission Definitions in a Randomized Controlled Trial of Colchicine Prophylaxis for People With Gout Initiating Allopurinol

A.D. Tabi-Amponsah, BBiomedSc(Hons), Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
L.K. Stamp, PhD, Department of Medicine, University of Otago, Christchurch, Christchurch.
A. Horne, MBChB, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
J. Drake, RN, Department of Rheumatology, Immunology and Allergy, Te Whatu Ora Health New Zealand Waitaha Canterbury, Christchurch.
S. Stewart, PhD, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, and School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland.
G. Gamble, MSc, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
K.J. Petrie, PhD, Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
N. Dalbeth, MD, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

ADTA is supported by a University of Auckland Health Research Doctoral Scholarship.
ND has received consulting or speaker fees from AstraZeneca, Dyve, Horizon, Selecta, Arthrosi, JW Pharmaceutical, PK Med, LG Chem, JPI, PTC Therapeutics, and Protalix, outside the submitted work. LKS has received royalties from UpToDate and consulting fees from Pharmac NZ. The remaining authors declare no conflicts of interest relevant to this article.
Accepted for publication July 5, 2024.

Address correspondence to Prof. N. Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 22-30 Park Ave, Grafton, Auckland 1023, New Zealand. Email: n.dalbeth@auckland.ac.nz.